Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof.
暂无分享，去创建一个
E. Schönbrunn | G. Reuther | H. Lawrence | Ryan R Davis | N. Lawrence | Baoli Li | M. Ayaz | S. Gunawan | A. Chan | Ryan R. Davis | S. Yun | P. Nareddy